EAS-Lyon 2024
We tested the hypothesis that machine learning could identify individuals in a UK primary care setting for whom personalised cholesterol-lowering therapy might be more appropriate than guideline-based recommendations.
DetailsWe tested the hypothesis that machine learning could identify individuals in a UK primary care setting for whom personalised cholesterol-lowering therapy might be more appropriate than guideline-based recommendations.
DetailsAI to Advance Prevention, Treatment, and Equity in UK Primary Care Metadvice recently presented alongside Lancing & Sompting PCN Clinical Director Dr Shona Schofield at the “Tackling Cholesterol Together Roadshow” hosted by HeartUK and Health Innovation Kent Surrey Sussex. The case study, based on over 12 months implementation in the Ball Tree Surgery in West…
DetailsInsulin: A Key Factor in the Nexus of Cardiometabolic Disease Andrew J Krentz Chief Medical Officer, Metadvice Defects of insulin secretion and/or action are central to the expanding worldwide pandemic of non-communicable cardiometabolic disorders (figure). In recent decades, large scale human overnutrition has fuelled exploding rates of obesity and type 2 diabetes. Uncommon a century…
Details